BKYI

BIO-Key International Inc

BKYI, USA

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, services, and cloud host, as well as windows device authentication through IAM platform. The company's solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and civil and large-scale ID infrastructure solutions that develop finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.

https://www.bio-key.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
BKYI
stock
BKYI

BIO-key International Inc. (BKYI) Stock Price | Live Quotes & Charts | NASDAQ StocksToTrade

Read more →
BKYI
stock
BKYI

BIO-key International (NASDAQ:BKYI) versus Viscount Systems (OTCMKTS:VSYS) Critical Analysis Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$2

Analyst Picks

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.76

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-15.96 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-9.54 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-72.54 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Medium

0.67

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 1.24% of the total shares of BIO-Key International Inc

1.

TWO SIGMA SECURITIES, LLC

(0.4252%)

since

2025/06/30

2.

Geode Capital Management, LLC

(0.385%)

since

2025/06/30

3.

UBS Group AG

(0.2062%)

since

2025/06/30

4.

GSA Capital Partners LLP

(0.194%)

since

2025/06/30

5.

Tower Research Capital LLC

(0.0262%)

since

2025/06/30

6.

SBI Securities Co Ltd

(0.0044%)

since

2025/06/30

7.

Bank of America Corp

(0.0007%)

since

2025/06/30

8.

HARBOUR INVESTMENTS, INC.

(0.0001%)

since

2025/06/30

9.

Goss Wealth Management LLC

(0.0001%)

since

2025/06/30

10.

Wells Fargo & Co

(0%)

since

2025/06/30

11.

Citigroup Inc

(0%)

since

2025/06/30

12.

Citadel Advisors Llc

(0%)

since

2025/03/31

13.

JPMorgan Chase & Co

(0%)

since

2025/06/30

14.

Armistice Capital, LLC

(0%)

since

2025/06/30

15.

Virtu Financial LLC

(0%)

since

2025/06/30

16.

Advisor Group Holdings, Inc.

(0%)

since

2025/06/30

17.

XTX Topco Ltd

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(2)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.